"Loading Stock Price & Valuation Data ..."
Unlock News Summary by Subscribing to iPick.ai Premium!
Ask anything related to CYDY. [ FAQ on what and how to ask] For non-CYDY questions, click the logo in the upper-right corner to return to the main page and ask there.
CEO:Dr. Jacob P. Lalezari M.D.
Headquarter: 1111 Main Street, Suite 660, Vancouver, WA, United States, 98660
Industry: Biotechnology, Investment Track: gene therapy - small, Employees: 13
CytoDyn Inc., a clinical-stage biotechnology company, develops treatments for multiple therapeutic indications. It is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19. The company's leronlimab is currently under phase 2 development for the treatment of micro-satellite stable colorectal cancer, and solid tumors in oncology, such as metastatic triple-negative breast cancer. It has a collaboration with Creatv Bio. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.
My Watchlist
